Obeticholic Acid
Back to searchMolecule Structure
Scientific Name
Obeticholic Acid
Description of the Drug
Obeticholic acid is a bile acid analog and farnesoid X receptor agonist used to treat primary biliary cholangitis in adult patients with inadequate clinical response or intolerance to UDCA.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB05990
http://www.drugbank.ca/drugs/DB05990
Brand Name(s)
Ocaliva
Company Owner(s)
Intercept Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bile acid receptor FXR | SINGLE PROTEIN | AGONIST | CHEMBL2047 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL715823 | |
| DrugBank | DB05990 | |
| PubChem: Thomson Pharma | 16101459 | 14880306 |
| PubChem | 447715 | |
| Nikkaji | J2.007.345D | |
| PDBe | CHC | |
| BindingDB | 21675 | |
| EPA CompTox Dashboard | DTXSID20196671 | |
| DrugCentral | 5155 | |
| Guide to Pharmacology | 3435 | |
| rxnorm | OBETICHOLIC ACID | OCALIVA |
| PubChem: Drugs of the Future | 123055342 | |
| KEGG Ligand | C15636 | |
| ChEBI | 43602 | |
| ZINC | ZINC000014164617 |
